Positive News for Two Undervalued Firms in the Prohost Portfolio
May 5, 2022
0
Exelixis CABOMETYX Approval Exelixis (EXEL) partner Ipsen received approval from the European Commission (EC) for CABOMETYX® (cabozantinib) as a …